MSM for Dogs with Arthritis: Evidence, Mechanism, and Practical Use

Joint supplements containing MSM have become nearly ubiquitous in the pet health aisle. If your dog has arthritis, you’ve likely encountered products promising relief through this ingredient. But does MSM actually help arthritic dogs, or is it another case of marketing outpacing science?

At PetEvidenceProject, we dig into the research so pet owners can make informed decisions. Here’s what the evidence actually shows about MSM for dogs with arthritis.

Quick Answer: Does MSM Help Dogs with Arthritis? 

Methylsulfonylmethane (MSM) is widely included in canine arthritis supplements, but there are no high-quality clinical trials in dogs demonstrating clear benefits for pain or mobility. Most of what we know about MSM in osteoarthritis comes from human and laboratory animal studies, not research conducted in arthritic dogs.

MSM appears biologically plausible as a joint support ingredient. Laboratory research suggests potential anti inflammatory effects, antioxidant properties, and a role as an organic sulfur donor for connective tissues. However, translating these mechanisms into real-world effectiveness for canine arthritis remains speculative.

Complicating matters further, MSM rarely appears alone in commercial products. It’s typically combined with glucosamine, chondroitin, green-lipped mussel, omega-3 fatty acids, and other ingredients. This makes it essentially impossible to determine which component (if any) deserves credit when a dog shows improvement.

Regarding safety, typical oral doses appear well tolerated in dogs. However, long-term high-dose safety has not been rigorously studied in the target species. Pet owners should view MSM as an unproven adjunct rather than a proven treatment.

What Is MSM and Why Is It in So Many Dog Arthritis Supplements?

 MSM (methylsulfonylmethane, also called dimethyl sulfone) is a small, sulfur-containing organic molecule classified as a dietary supplement for both humans and animals. It’s marketed as a naturally occurring sulfur compound, though commercial MSM for supplements is almost always synthetically produced—typically derived from dimethyl sulfoxide (DMSO) under controlled manufacturing conditions, not “harvested from rainwater” as some marketing suggests.

Sulfur is an essential element in your dog’s body. It’s incorporated into amino acids like methionine and cysteine, plays a role in collagen production, and supports connective tissues throughout joints, skin, and coat. This is why MSM gets marketed as a “sulfur donor” that may benefit joint health, skin health, and coat health.

MSM is classified as “Generally Recognized as Safe” (GRAS) for certain food and feed applications. However, GRAS status pertains to safety at typical use levels—it does not prove that MSM is effective for treating arthritis or any other condition. This distinction matters: something can be safe to consume without actually providing therapeutic benefits.

How Might MSM Work for Arthritis? (Mechanism of Action) 

Understanding proposed mechanisms helps educate pet owners about why MSM sounds reasonable—even when clinical proof is lacking. Most proposed mechanisms for MSM in arthritis come from cell culture experiments, rodent models, and human data. In dogs, these mechanisms are inferred rather than directly proven.

Sulfur Donor Hypothesis MSM is theorized to provide bioavailable sulfur that supports synthesis of cartilage matrix components, including glycosaminoglycans critical for cartilage hydration and joint function. Sulfur also forms disulfide bonds in collagen and keratin, providing structural integrity to connective tissues.

The catch: there’s no strong evidence that otherwise healthy dogs consuming complete commercial diets are sulfur-deficient. Most quality dog food contains adequate methionine and cysteine (sulfur-containing amino acids). Whether adding extra sulfur through MSM provides meaningful benefit for cellular health and tissue repair remains uncertain.

Proposed Anti-Inflammatory Effects Laboratory research suggests MSM may down-regulate pro-inflammatory cytokines like IL-1β (interleukin-1 beta) and TNF-α (tumor necrosis factor-alpha). Some studies indicate it might inhibit COX-2 expression, similar to how many anti inflammatory medications work.

These effects have been observed primarily in cell cultures and rodent osteoarthritis models—not in dogs with naturally occurring arthritis. The translation from petri dish to living dog involves substantial biological uncertainty.

Antioxidant Properties MSM may help reduce oxidative stress by enhancing glutathione production and scavenging reactive oxygen species. Since oxidative stress is implicated in cartilage degeneration, this mechanism has theoretical appeal.

However, demonstrating antioxidant activity in laboratory settings doesn’t guarantee clinical benefit in a complex living animal. Direct antioxidant benefit in dogs with osteoarthritis has not been demonstrated.

Effects on Pain Pathways Some researchers hypothesize that MSM affects nociceptive signaling and membrane fluidity, potentially altering pain perception and providing relief from joint discomfort. This proposed mechanism is not well characterized and remains speculative.

The essential caveat: These mechanisms are biologically plausible but largely hypothetical when applied to dogs with arthritis. They support the idea that MSM could help, not that it does help.

What Does the Evidence Say? (Dogs vs. Other Species) 

Here’s where the rubber meets the road. There are currently no robust, placebo-controlled clinical trials evaluating MSM alone for naturally occurring osteoarthritis in pet dogs.

Canine and Feline Evidence: Barbeau-Grégoire et al. 2022 A systematic review and meta-analysis published in the International Journal of Molecular Sciences evaluated enriched therapeutic diets and nutraceuticals for canine and feline osteoarthritis.

Key findings:

• Strongest evidence of analgesic benefit: Omega-3 enriched diets and omega-3 supplements
• Moderate benefit: Cannabidiol (to a lesser degree)
• Weak efficacy: Collagen
• Very marked non-effect: Chondroitin-glucosamine combinations

The authors explicitly recommended that chondroitin-glucosamine products “should no longer be recommended for pain management in canine and feline osteoarthritis” (Barbeau-Grégoire et al., 2022). MSM-containing combinations were not supported by strong, high-quality clinical data in dogs.

Human Evidence: Brien et al. 2008 A systematic review in Osteoarthritis and Cartilage examined DMSO and MSM for human osteoarthritis, mainly of the knee.

The findings were sobering:

• Many DMSO studies had poor methodology, including possible unblinding and questionable dosing
• Better-designed MSM trials provided “positive but not definitive evidence that MSM is superior to placebo in the treatment of mild to moderate OA of the knee” (Brien et al., 2008)

Even in humans, where multiple clinical trials have been conducted, the evidence remains inconclusive.

Rodent Evidence: Ezaki et al. 2013 This study examined MSM in two rodent models with mixed results:

• Growing Rat Model (4 Weeks): Showed no effect on cartilage formation. High doses were associated with lower body, liver, and spleen weights, suggesting potential systemic risks during growth (Ezaki et al., 2013).
• STR/Ort Mouse OA Model (13 Weeks): Demonstrated a dose-dependent decrease in cartilage degeneration, supporting a protective role in existing joint disease (Ezaki et al., 2013).

The authors noted that while appropriate MSM intake showed possible benefit in OA model mice, “intake of large amounts of MSM induced atrophy of several organs.” This raises important safety questions about high-dose, chronic use.

Military Working Dogs: Lee et al. 2018 A study examined a botanical supplement blend (including MSM among other ingredients) in healthy military working dogs, measuring inflammatory markers.

Critical limitations:

• This was not an arthritis trial
• The supplement contained multiple ingredients, preventing isolation of MSM’s effects
• IL-6 did not differ significantly between groups (Lee et al., 2018)
• CRP increased at 8 weeks, then decreased by 16 weeks

This study cannot support claims about MSM’s effectiveness for arthritis in dogs.

Extrapolating from Human and Laboratory Studies: How Speculative Is It? Pet supplement marketing often extrapolates from human and rodent data to justify use in dogs. This approach has significant limitations that pet owners should understand.

Problems with Human Data Extrapolation When manufacturers cite Brien et al. 2008, they’re using evidence that even in humans is “positive but not definitive” (Brien et al., 2008). Additional issues include:

• Pharmacokinetics differ: Absorption, distribution, metabolism, and excretion may vary substantially between humans and dogs
• Joint biomechanics differ: Humans are bipedal; dogs are quadrupedal with different loading patterns on the hip joint and other animals’ joints
• Outcome measures differ: Human trials measure subjective pain scales and functional assessments that don’t translate directly to canine evaluation

Using inconclusive human evidence to make strong claims about canine efficacy is not scientifically justified.

Problems with Rodent Data Extrapolation The Ezaki 2013 study shows positive signals in mice but raises concerns:

• Rodent joints are vastly smaller with different cartilage structure
• Doses beneficial in mice may be subtherapeutic or toxic in large-breed dogs
• High doses that helped mouse cartilage also caused organ atrophy (Ezaki et al., 2013)
• Spontaneous OA in one mouse strain doesn’t represent the diversity of canine arthritis presentations

PetEvidenceProject’s Interpretation 

We treat MSM as a low-certainty option where:

• Mechanism and non-canine data suggest possible benefit
• Insufficient dog-specific clinical proof exists
• Language should remain cautious: “may,” “might,” “theorized to,” “has not been proven in dogs”

Evidence Level Summary: Overall evidence for MSM in canine arthritis is very low, based mainly on non-canine data with no direct clinical trials in arthritic dogs.

MSM in Combination Products for Canine Arthritis Most MSM in the canine arthritis market isn’t sold alone. It appears in multi-ingredient joint supplements, soft chews, chewable tablets, MSM powder formulations, and therapeutic diets.

Common Combinations

• MSM with glucosamine and chondroitin sulfate (the most common formulation)
• MSM with green-lipped mussel and omega-3s
• MSM with collagen, boswellia, or turmeric
• MSM with vitamins and other nutrients for nutrient absorption

The Attribution Problem When your dog shows improved mobility on a combination product, which ingredient deserves credit? This is essentially impossible to determine.

The problem deepens when you consider that Barbeau-Grégoire 2022 found chondroitin-glucosamine has a “very marked non-effect” for pain management (Barbeau-Grégoire et al., 2022). If these commonly paired ingredients don’t work, any perceived benefit from combination products likely comes from:

• Omega-3s (which have strong evidence)
• Placebo effect (owner expectation)
• Concurrent changes (weight loss, weather, natural disease fluctuation)
• Other factors unrelated to supplements

How PetEvidenceProject Views Combinations 

MSM is often a key ingredient in formulations more for marketing than proven efficacy. It’s inexpensive, sounds scientific, and allows manufacturers to list additional “active ingredients.”

We recommend pet owners:

• Prioritize products where at least some components (like EPA/DHA omega-3s) have direct canine evidence
• View MSM as an unproven adjunct, not the primary active ingredient
• Be skeptical of products that rely heavily on chondroitin-glucosamine given the negative evidence (Barbeau-Grégoire et al., 2022)

Safety, Dosing, and Practical Use in Dogs 

MSM appears to have a favorable safety profile at commonly used doses, but dog-specific long-term data at high doses remain limited. The Veterinary Therapeutics literature indicates MSM demonstrates an excellent safety margin in canines at recommended levels.

However, the Ezaki 2013 study raises a caution flag: high-dose MSM in rodents was associated with decreased liver and spleen weights (Ezaki et al., 2013). The border radius between beneficial and potentially harmful doses is not clearly defined for dogs.

Potential side effects at standard doses:

• Mild gastrointestinal upset (soft stools, decreased appetite)
• Increased thirst or urination
• Possible digestive health changes during initial introduction

Practical Considerations 

Before adding MSM or any supplement for dogs, consult your veterinarian, especially if your dog has:

• Liver or kidney disease
• Gastrointestinal conditions
• Multiple medications

Avoid stacking multiple MSM-containing products. Many joint supplements, joint chews, and food toppers contain MSM, potentially pushing total intake well beyond studied levels.

Evidence-Based OA Management Cornerstones 

MSM should never replace veterinary guidance or interventions with demonstrated benefit:

• Ideal body weight: Weight management is one of the strongest controllable factors
• NSAIDs and analgesics: FDA-approved options provide established pain relief under veterinary supervision
• Omega-3 enriched diet or supplements: Strong evidence from Barbeau-Grégoire 2022 (Barbeau-Grégoire et al., 2022)
• Physical rehabilitation: Controlled exercise, therapeutic activities
• Environmental modifications: Orthopedic bedding, ramps, temperature control

MSM, if used, should be viewed as an optional adjunct within this broader framework—not a cure or stand-alone treatment for your pet’s well being.

How PetEvidenceProject Interprets MSM for Canine Arthritis 

Here’s our bottom-line assessment for pet owners considering MSM:

• Biological Plausibility: Moderate. Theories suggest MSM may act as an anti-inflammatory, antioxidant, or sulfur donor for connective tissue, providing a rational basis for its use.
• Direct Canine Clinical Evidence: Very low to absent. There is a significant lack of high-quality, peer-reviewed clinical trials specifically testing MSM as a standalone treatment in dogs.
• Evidence from Other Species: Mixed. While some positive signals have been observed in other animal models (Ezaki et al., 2013), they are not yet definitive enough to apply directly to canine health.
• Recommendation: Low-certainty option / experimental adjunct. MSM is best viewed as a supportive addition to a primary joint health plan rather than a primary treatment.

Stronger support exists for other interventions. Weight control, omega-3s, veterinary-prescribed NSAIDs, and physical rehabilitation all have better evidence bases and should be prioritized.

If You Still Want to Try MSM

• Work in collaboration with your vet
• Maintain realistic expectations (possible mild joint comfort improvement, but many dogs show no clear change)
• Continue proven therapies rather than replacing them
• Monitor for any adverse effects and report them to your veterinarian
• Contact your vet if you notice any concerning symptoms

PetEvidenceProject will update this assessment if new, well-designed dog clinical trials on MSM and osteoarthritis pain or joint function become available. Our commitment is to evolving, evidence-based guidance—not marketing claims.

For now, MSM remains an unproven ingredient with theoretical appeal but without the clinical data needed to recommend it confidently for canine arthritis. Focus first on what we know works, and treat MSM supplementation as an optional experiment rather than established medicine.